| 注册
首页|期刊导航|中医学报|青蒿素及其衍生物抗肝癌研究进展

青蒿素及其衍生物抗肝癌研究进展

裴晶 朱宇同 宋健平 李国桥 张美义

中医学报2011,Vol.26Issue(3):267-269,3.
中医学报2011,Vol.26Issue(3):267-269,3.

青蒿素及其衍生物抗肝癌研究进展

Progress in the Research on the Anti - Hepatic Carcinoma Ability of Artermisinin

裴晶 1朱宇同 1宋健平 1李国桥 1张美义1

作者信息

  • 1. 广州中医药大学,广东,广州,510405
  • 折叠

摘要

Abstract

Objective:To investigate the inhibitory effect of Artemisia and its derivatives on hepatocarcinoma. Methods:Review the inhibitory effect and the prospect of Artemisia and its derivatives on hepatocarcinoma by searching relevant literature and organizing experimental data in vivo and vitro in recent years. Results:Artemisia and its derivatives can inhibit hepatocarcinoma growth whether in vivo and vitro experiment or clinical practice, they play anti - tumor effect by inducing apoptosis, inhibiting cell proliferation, inhibiting angiogenesis, and producing free radicals. Conclusion: Artemisia and its derivatives have obvious anti - hepatocarcinoma activities,it is expected to become the new anti - hepatocarcinoma drug of high efficiency and low toxicity.

关键词

青蒿素/青蒿素衍生物/活性机制/抗肝癌/综述

Key words

Artemisinin/ Artemisinin and its derivatives/ activity/ hepatocarcinoma/ mechanism

分类

医药卫生

引用本文复制引用

裴晶,朱宇同,宋健平,李国桥,张美义..青蒿素及其衍生物抗肝癌研究进展[J].中医学报,2011,26(3):267-269,3.

基金项目

国家中药材扶持项目(编号:广东/39). (编号:广东/39)

中医学报

OACSTPCD

1674-8999

访问量0
|
下载量0
段落导航相关论文